Actinogen Medical Limited (AU:ACW) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Actinogen Medical Ltd., a biotechnology firm listed on the ASX, announced the successful passing of all resolutions in its recent Annual General Meeting, including a special resolution to increase placement capacity. The company is progressing with its promising drug Xanamem, aimed at treating Alzheimer’s and depression by targeting brain cortisol levels, with positive trial results already reported. Investors are keenly watching its ongoing trials, which could significantly impact the firm’s future performance in the neurological treatment space.
For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.
